Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 6, 2012, Pages 573-583

  Bernard, Marie Agnès ^a,b   Bénichou, Jacques ^a,c   Blin, Patrick ^b   Weill, Alain ^d   Bégaud, Bernard ^a,b,e   Abouelfath, Abdelilah ^b   Moore, Nicholas ^a,b,e   Fourrier Réglat, Annie ^a,b,e  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Pharmacoepidemiology; Predictive model; Prescription databases; Rheumatoid arthritis

Indexed keywords

CELECOXIB; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG INDICATION; DRUG USE; FEMALE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NURSING INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; VALIDATION PROCESS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DRUG UTILIZATION REVIEW; FEMALE; FRANCE; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; YOUNG ADULT;

EID: 84862198999     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3221     Document Type: Article

References (19)

1. Hennessy S. Use of health care databases in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 2006; 98(3): 311.
2. Goettsch WG, Heintjes EM, Kastelein JJ, et al. Results from a rosuvastatin historical cohort study in more than 45, 000 Dutch statin users, a PHARMO study. Pharmacoepidemiol Drug Saf 2006; 15(7): 435.
3. Levy L, Martin-Guehl C, Lechevallier-Michel N, et al. Use of psychotropic drugs in 0 to 5years old children in Aquitaine (France): prevalence and associated factors. Pharmacoepidemiol Drug Saf 2006; 15(7): 504.
4. Martin K, Begaud B, Latry P, et al. Differences between clinical trials and postmarketing use. Br J Clin Pharmacol 2004; 57(1): 86.
5. Deprez P, Chinaud F, Clech S, et al. La population traitée par médicaments de la classe des antiasthmatiques en France métropolitaine: données de l'assurance maladie, 2000. Rev Med Ass Maladie 2004; 35(1): 3.
6. Galula G, Buffet C, Robba L, et al. Assessment of prescription practices for serological tests for viral hepatitis B and C in the Greater Parisian area in 2002. Gastroenterol Clin Biol 2006; 30(4): 517.
7. Moore N, Diris H, Martin K, et al. NSAID use profiles derived from reimbursement data in France. Therapie 2004; 59(5): 541.
8. Depont F, Fourrier A, Merliere Y, et al. The CADEUS study: methods and logistics. Pharmacoepidemiol Drug Saf 2007a; 16(5): 571.
9. Depont F, Fourrier A, Merliere Y, et al. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf 2007b; 16(8): 891.
10. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358(9285): 903.
11. Beattie P, Nelson R. Clinical prediction rules: what are they and what do they tell us? Aust J Physiother 2006; 52(3): 157.
12. Combe B. Les facteurs de pronositc des rhumatismes inflammatoires au début de la maladie. Rev Med Interne 1996; 17: 224.
13. Weyand CM, Schmidt D, Wagner U, et al. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 1998; 41(5): 817.
14. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143(1): 29.
15. Moise A, Salamon R, Commenges D, et al. L'utilisation des courbes ROC. Rev Epidem et Santé Publ 1986; 34: 209.
16. Fourrier-Reglat A, Droz-Perroteau C, Benichou J, et al. Impact of prescriber nonresponse on patient representativeness. Epidemiology 2008; 19(2): 186.
17. Raza K, Buckley CE, Salmon M, et al. Treating very early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2006; 20(5): 849.
18. Srikanth A, Deighton C. Management of rheumatoid arthritis. Medicine 2006; 34(10): 387.
19. Moore N, Verschuren X, Montout C, et al. Excess costs related to non-steroidal anti-inflammatory drug utilisation in general practice. Therapie 2000; 55(1): 133.